Company: BLRX
Filing Date: 2025-03-31
Form Type: 20-F
Source: 0001178913-25-001123
Chunk: 52

Company: BioLineRx Ltd.
Filing Date: 2025-03-31
Form: 20-F
Item: Item 3
Chunk 52
---
 officers, which may make it difficult to collect on judgments
rendered against us or our non-U. S. officers and directors.

Your rights and responsibilities
as a shareholder will be governed by Israeli law, which may differ in some respects from the rights and responsibilities of shareholders
of U. S. companies.

We are incorporated under Israeli law. The rights and responsibilities
of the holders of our ordinary shares are governed by our Articles of Association and Israeli law. These rights and responsibilities differ
in some respects from the rights and responsibilities of shareholders in typical U. S.-based corporations. In particular, pursuant to the
Companies Law, a shareholder of an Israeli company has a duty to act in good faith and in a customary manner toward the company and other
shareholders, and to refrain from abusing its power in the company, including, among other things, in voting at the general meeting of
shareholders on amendments to a company’s articles of association, increases in a company’s authorized share capital, mergers
and acquisitions and interested party transactions requiring shareholder approval under the Companies Law, as well as a general duty to
refrain from discriminating against other shareholders. In addition, a controlling shareholder and a shareholder who knows that it possesses
the power to determine the outcome of a shareholder vote or to appoint or prevent the appointment of a director or executive officer in
the company or has other powers toward the company, has a duty of fairness toward the company. Israeli law does not define the substance
of this duty of fairness and there is limited case law available to assist us in understanding the nature of these duties or the implications
of these provisions. These provisions may be interpreted to impose additional obligations and liabilities on holders of our ordinary shares
that are not typically imposed on shareholders of U. S. corporations.

ITEM 4. INFORMATION
ON THE COMPANY

A. History and Development of the Company

Our legal and commercial name is BioLineRx Ltd. We are a company
limited by shares organized under the laws of the State of Israel. Our principal executive offices are located at 2 HaMa’ayan Street,
Modi’in 7177871, Israel, and our telephone number is +972 (8) 642-9100. Our wholly owned subsidiary, BioLineRx USA, Inc., was incorporated
in Delaware on January 4, 2008, and is located at 77 Fourth Ave, Waltham, Massachusetts 02451.

We were founded in 2003 by leading institutions in the Israeli